ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Manager/Sr. Manager, Training and Doc Control Support Systems at BridgeBio Pharma - ApplyBlast

Manager/Sr. Manager, Training and Doc Control Support Systems

BridgeBio Pharma

5 months ago

San Francisco, CA

Hybrid

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Document Control & Training Manager at BridgeBio leads quality documentation activities and trains employees on GxP compliance using Veeva systems. This senior role ensures all regulatory records adhere to Good Documentation Practices while managing electronic document management and learning management processes. The position requires close collaboration with Quality Control, Manufacturing, and Regulatory Affairs to maintain the integrity of quality systems.

Responsibilities

Lead document control compliance and process improvement efforts
Manage electronic document management systems for quality records
Oversee training programs and learner roles within the LMS
Coordinate document periodic reviews with internal stakeholders
Facilitate readiness for regulatory audits and inspections

Skills

Qualifications

Bachelor's degree or higher5-10 years of experience in pharmaceutical Quality Assurance

About BridgeBio Pharma

bridgebio.com

Headquarters

Palo Alto, California, United States

Company Size

201-500 employees

Founded

2014

View Profile

BridgeBio is a biotechnology company designing transformative medicines for patients with genetic diseases and cancers driven by clear genetic causes. The company advances programs from target discovery through clinical development, combining human genetics and translational science with rigorous clinical trials to create targeted therapeutics. BridgeBio builds a diversified portfolio of wholly owned and partnered programs across multiple modalities and uses a venture‑style operating model to accelerate and de‑risk development. Its mission is to translate genetic insights into precision medicines for patients with high unmet medical need.